|
Michel Goldman (born 1 January 1955) is a Belgian medical doctor who specialized in internal medicine and immunology. == Biography == Michel Goldman graduated as a Medical Doctor (1978) from Université Libre de Bruxelles (ULB), Belgium, and received his PhD in medical sciences (1981) from Université de Genève, Switzerland. He is board certified in internal medicine (1984) and clinical biology (1993). From 1990 to 2008, he heads of the Department of Immunology-Hematology-Transfusion at Erasme Hospital in Brussels, and from 2004 to 2009 serves as the first Director of the Institute for Medical Immunology built on the Charleroi campus of ULB, with the support of GSKBiologicals and the Walloon Region. In 2009, Michel Goldman becomes the first Executive Director of the Innovative Medicines Initiative (IMI) 〔(【引用サイトリンク】title=Professor Michel Goldman, Innovative Medicines Initiative )〕 a joint undertaking between the European Commission and the European Federation of Pharmaceutical Industries and Associations. Managing a budget of €2 billion, he has been responsible for the launch of 59 public-private consortia in areas of major importance, including antimicrobial resistance, Alzheimer's dementia, cancer, diabetes, immuno-inflammatory disorders, autism, chronic pulmonary diseases and drug safety.〔(【引用サイトリンク】title=Michel Goldman, MD, PhD - Events - Health - Research & Innovation - European Commission )〕 Michel Goldman is Professor of Immunology and Pharmacotherapy at ULB. He is a member of the Board of Directors of CQDM (Canadian consortium for precompetitive research)〔(【引用サイトリンク】title=Michel Goldman, MD, PhD - Member of CQDM's board )〕 , of the Board of the Tuberculosis Vaccine Initiative〔(【引用サイトリンク】title=Dr Michel Goldman - Member of TBVI board )〕 and of the Strategic and Scientific Advisory Board of GenomeQuebec. He also serves as chairman of the Scientific Committee of Effimune S.A., a French biotechnology company.〔(【引用サイトリンク】title=Michel Goldman named Chairman of Scientific Advisory Board )〕 Starting September 2015, Michel Goldman will lead the Institute for Interdisciplinary Innovation in Healthcare (I3h), a ULB centre that has the mission of fostering research, education and outreach networks for the benefit of patients and other stakeholders. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Michel Goldman」の詳細全文を読む スポンサード リンク
|